companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

ROCHE FINANCIAL GROUP

PETERBOROUGH-Canada

Company Name:
Corporate Name:
ROCHE FINANCIAL GROUP
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 2137 Lynhaven Rd,PETERBOROUGH,ON,Canada 
ZIP Code:
Postal Code:
K9K1Y6 
Telephone Number: 7058768555 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
628205 
USA SIC Description:
Financial Planning Consultants 
Number of Employees:
1 to 4 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Good 
Contact Person:
Linda Stephens 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
ROCK HAVEN MOTOR HOTEL LTD
ROCK & ROPE CLIMBING CTR
ROCHON BUILDING CORP
Next company profile:
ROBYNS MOTEL
ROBYNS MOTEL
ROBOCK EDWARD L DR OPTOMTRST










Company News:
  • Roche - Doing now what patients need next
    Learn more about exciting career opportunities at Roche, one of the world's leading research-based healthcare companies We focus on discovering new medicines, diagnostics and digital health solutions that improve health outcomes so that we all have more time with the people we love
  • Roche Diagnostics
    Explore innovative solutions and expert-led workshops as we work together to streamline lab medicine and diagnostics, advancing patient care Highlighting 40 years of pathology innovation with VENTANA®
  • Roche | About Roche
    Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
  • Roche - Wikipedia
    F Hoffmann-La Roche AG, commonly known as Roche ( rɒʃ ), is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics
  • Roche | Product Development Portfolio
    This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country
  • Roche Pharmaceuticals
    Roche has brought many highly effective drugs onto the market and is a world leader in innovative cancer drugs Other areas include viral infections, central nervous system disorders and inflammatory diseases
  • Our business - Roche
    With our diagnostics solutions, medicines and digital products, we will address patient needs along their entire journey - innovating from prevention and screening, to diagnosis, treatment and monitoring, meeting patients where they are and creating more comprehensive offerings
  • [Ad hoc announcement pursuant to Art. 53 LR] Roche provides . . .
    About Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world We are a
  • Roches COPD drug flunks ph. 3, denting hopes of 2025 approval
    Roche’s hopes of getting astegolimab to regulators this year took a hit after the anti-ST2 antibody failed to reduce flare-ups in a phase 3 study
  • About Us - Roche Diagnostics USA
    Roche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer